Weizhen Xu

发表

Poly(Adenosine 5'-diphosphate-ribose) polymerase inhibition counteracts multiple manifestations of experimental type 1 diabetic nephropathy.

Jie Zhang, B. Slusher, I. Obrosova, 2009, Endocrinology.

Poly(ADP-Ribose) Glycohydrolase Activity Mediates Post-Traumatic Inflammatory Reaction after Experimental Spinal Cord Trauma

E. Mazzon, S. Cuzzocrea, P. Bramanti, 2006, Journal of Pharmacology and Experimental Therapeutics.

PARG activity mediates intestinal injury induced by splanchnic artery occlusion and reperfusion

E. Mazzon, S. Cuzzocrea, Zhao-Qi Wang, 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

New therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-{alpha}.

Jie Zhang, N. Delamere, I. Vareniuk, 2010, Endocrinology.

Poly(ADP-ribose)polymerase inhibition counteracts cataract formation and early retinal changes in streptozotocin-diabetic rats.

Jie Zhang, Jeho Shin, B. Slusher, 2009, Investigative ophthalmology & visual science.

Inhibition of poly(ADP‐ribose) polymerase prevents irinotecan‐induced intestinal damage and enhances irinotecan/temozolomide efficacy against colon carcinoma

E. Mazzon, S. Cuzzocrea, C. Leonetti, 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Poly(ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat model.

Jie Zhang, B. Slusher, I. Obrosova, 2010, Biochemical pharmacology.

Poly(ADP-ribose) polymerase (PARP) inhibition or PARP-1 gene deletion reduces angiogenesis.

C. Leonetti, M. Scarsella, Zhao-Qi Wang, 2007, European journal of cancer.

PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy.

Jie Zhang, I. Vareniuk, N. Mashtalir, 2008, Free radical biology & medicine.

Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphoma.

C. Leonetti, M. Scarsella, G. Zupi, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Head and neck cancer radiosensitization by the novel poly(ADP‐ribose) polymerase inhibitor GPI‐15427

Jie Zhang, B. O'Malley, K. Araki, 2009, Head & neck.

Structural optimization of thiol-based inhibitors of glutamate carboxypeptidase II by modification of the P1' side chain.

Qun Liu, T. Tsukamoto, B. Slusher, 2006, Journal of medicinal chemistry.

Interferon-γ-induced regulation of the pancreatic derived cytokine FAM3B in islets and insulin-secreting βTC3 cells

B. Wolf, Jianmei Wu, Zhiyong Gao, 2005, Molecular and Cellular Endocrinology.

Treatment with a novel poly(ADP-ribose) glycohydrolase inhibitor reduces development of septic shock-like syndrome induced by zymosan in mice

S. Cuzzocrea, Jie Zhang, T. Genovese, 2004, Critical care medicine.

Solanum nigrum polysaccharide inhibits tumor growth in H22-bearing mice through regulation of caspase-3 and bcl-2

Yueyan Huang, Baoyue Ding, Weizhen Xu, 2018, Journal of cancer research and therapeutics.

Treatment with PARP-1 inhibitors, GPI 15427 or GPI 16539, ameliorates intestinal damage in rat models of colitis and shock.

E. Mazzon, S. Cuzzocrea, Jie Zhang, 2005, European journal of pharmacology.

Reaction of Resorcinol With Acetone.

T. Webb, Weizhen Xu, P. Livant, 1996, The Journal of organic chemistry.

Dietary Flavonoids as Cancer Prevention Agents

Xianglin Shi, Zhuo Zhang, HUA YAO, 2011, Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews.

Pancreatic-derived factor (FAM3B), a novel islet cytokine, induces apoptosis of insulin-secreting beta-cells.

B. Wolf, J. Markmann, A. Naji, 2003, Diabetes.

Role of poly(ADP-ribose) glycohydrolase in the development of inflammatory bowel disease in mice.

E. Mazzon, S. Cuzzocrea, Zhao-Qi Wang, 2007, Free radical biology & medicine.

Poly(ADP-ribose)polymerase inhibition counteracts renal hypertrophy and multiple manifestations of peripheral neuropathy in diabetic Akita mice.

Jie Zhang, P. Pacher, B. Slusher, 2011, International journal of molecular medicine.

Brain distribution and efficacy as chemosensitizer of an oral formulation of PARP-1 inhibitor GPI 15427 in experimental models of CNS tumors.

C. Leonetti, M. Scarsella, L. Tentori, 2005, International journal of oncology.

Sirtuin inhibition increases the rate of non-homologous end-joining of DNA double strand breaks.

M. Kruszewski, I. Buraczewska, M. Wojewódzka, 2007, Acta biochimica Polonica.

Pharmacological inhibition of poly ( ADP-ribose ) polymerase activity down-regulates the expression of syndecan-4 and Id-1 in endothelial cells

L. Tentori, P. Lacal, Jie Zhang, 2022 .

In vitro and In vivo Radiosensitization of Glioblastoma Cells by the Poly (ADP-Ribose) Polymerase Inhibitor E7016

K. Camphausen, A. Chakravarti, P. Tofilon, 2009, Clinical Cancer Research.

Poly(ADP-ribose)polymerase inhibition counteracts renal hypertrophy and multiple manifestations of peripheral neuropathy in diabetic Akita mice.

Jie Zhang, P. Pacher, B. Slusher, 2011, International journal of molecular medicine.

Reaction of Resorcinol with alpha,beta-Unsaturated Ketones.

Weizhen Xu, P. Livant, 1998, The Journal of organic chemistry.

LncRNA PWRN2 promotes polycystic ovary syndrome progression via epigenetically reducing ATRX by recruiting LSD1.

Xinlei Shi, Weizhen Xu, H. Sui, 2023, Reproductive biology.